Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX Showing element 1751 to 1800 of 3206 in total 

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1751\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR ATP SYNTHASE SUBUNIT G 2 (EC 3.6.3.14) (V-ATPASE G SUBUNIT 2) (VACUOLAR PROTON PUMP G SUBUNIT 2) (V-ATPASE 13 KDA SUBUNIT 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0861167\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.363797\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236716356\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1752\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SECRETORY PATHWAY COMPONENT SEC31B-1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.107954\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.456048\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236716311\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SEC31B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1753\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SEC13-RELATED PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.126518\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.534471\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236716305\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SEC13\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1754\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR ATP SYNTHASE SUBUNIT G 3 (EC 3.6.3.14) (V-ATPASE G SUBUNIT 3) (VACUOLAR PROTON PUMP G SUBUNIT 3) (V-ATPASE 13 KDA SUBUNIT 3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0486762\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.205631\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236716254\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP6V1G3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1755\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
APOPTOSIS INHIBITOR 5; FIBROBLAST GROWTH FACTOR 2-INTERACTING FACTOR 2; API5-LIKE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0646874\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.27327\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236716068\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
API5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1756\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR ATP SYNTHASE SUBUNIT G 1 (EC 3.6.3.14) (V-ATPASE G SUBUNIT 1) (VACUOLAR PROTON PUMP G SUBUNIT 1) (V-ATPASE 13 KDA SUBUNIT 1) (VACUOLAR ATP SYNTHASE SUBUNIT M16). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.063055\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.266374\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236716046\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP6V1G1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1757\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.420128\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.77482\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236715836\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP6V1E2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1758\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"DEAD (ASP-GLU-ALA-ASP) BOX POLYPEPTIDE 39 ISOFORM 1; NUCLEAR RNA HELICASE, DECD VARIANT OF DEAD BOX FAMILY. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0299559\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.126548\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236715713\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DDX39\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1759\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"VACUOLAR ATP SYNTHASE SUBUNIT B, KIDNEY ISOFORM (EC 3.6.3.14) (V- ATPASE B1 SUBUNIT) (VACUOLAR PROTON PUMP B ISOFORM 1) (ENDOMEMBRANE PROTON PUMP 58 KDA SUBUNIT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.299765\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.26636\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236713889\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP6V1B1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1760\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR ATP SYNTHASE SUBUNIT F (EC 3.6.3.14) (V-ATPASE F SUBUNIT) (VACUOLAR PROTON PUMP F SUBUNIT) (V-ATPASE 14 KDA SUBUNIT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.424679\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.79432\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236679634\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP6V1F\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1761\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
O-SIALOGLYCOPROTEIN ENDOPEPTIDASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.346601\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.46589\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236444072\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
OSGEP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1762\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RUVB-LIKE 2 (EC 3.6.1.-) (48-KDA TATA BOX-BINDING PROTEIN-INTERACTING PROTEIN) (48-KDA TBP-INTERACTING PROTEIN) (TIP49B) (REPRESSING PONTIN 52) (REPTIN 52) (51 KDA ERYTHROCYTE CYTOSOLIC PROTEIN) (ECP-51) (TIP60-ASSOCIATED PROTEIN 54-BETA) (TAP54-BETA) (CG\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.245894\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.04017\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236397896\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RUVBL2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1763\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ATPASE, H+ TRANSPORTING, LYSOSOMAL 38KDA, V0 SUBUNIT D ISOFORM 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.33278\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.40872\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236228633\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP6V0D2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1764\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0607427\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.257167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236199435\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1765\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLUTATHIONE S-TRANSFERASE P (EC 2.5.1.18) (GST CLASS-PI) (GSTP1-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.208499\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.882968\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236134265\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GSTP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1766\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"DJ850E9.1 (NOVEL C2H2 TYPE ZINC FINGER PROTEIN SIMILAR TO DROSOPHILA SCRATCH (SCRT), SLUG AND XENOPUS SNAIL) (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.281698\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.1936\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236007038\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1767\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
THYROID RECEPTOR INTERACTING PROTEIN 12 (TRIP12). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0325717\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.138013\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236004579\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TRIP12\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1768\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE COMPONENT OF 2-OXOGLUTARATE DEHYDROGENASE COMPLEX, MITOCHONDRIAL PRECURSOR (EC 2.3.1.61) (E2) (E2K). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.660595\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.79908\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23600433\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DLSTP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1769\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PEROXISOMAL MEMBRANE PROTEIN 2 (22 KDA PEROXISOMAL MEMBRANE PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0420153\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.178036\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.235993282\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PXMP2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1770\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HEAT SHOCK-RELATED 70 KDA PROTEIN 2 (HEAT SHOCK 70 KDA PROTEIN 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0660691\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.279962\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.235993099\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HSPA2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1771\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HEAT SHOCK COGNATE 71 KDA PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.126046\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.534109\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.235993028\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HSPA8\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1772\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HEAT SHOCK 70 KDA PROTEIN 1 (HSP70.1) (HSP70-1/HSP70-2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0654179\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.277203\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.235992756\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1773\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"RIBOSOMAL PROTEIN P0-LIKE PROTEIN; 60S ACIDIC RIBOSOMAL PROTEIN PO; RIBOSOMAL PROTEIN, LARGE, P0-LIKE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.797221\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.37861\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.235961238\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MRTO4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1774\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"DIHYDROLIPOAMIDE DEHYDROGENASE, MITOCHONDRIAL PRECURSOR (EC 1.8.1.4) (GLYCINE CLEAVAGE SYSTEM L PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.596138\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.52689\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23591767\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DLD\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1775\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SCRATCH; SCRATCH 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.322861\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.36866\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.235895694\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1776\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.103336\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.438523\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.235645565\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
WDR70\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1777\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDA11 PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.378654\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.60733\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.235579501\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TATDN1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1778\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARGININOSUCCINATE SYNTHASE (EC 6.3.4.5) (CITRULLINE--ASPARTATE LIGASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.161564\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.685844\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.235569605\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ASS1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1779\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RETINOL DEHYDROGENASE 8 (ALL-TRANS); PHOTORECEPTOR OUTER SEGMENT ALL-TRANS RETINOL DEHYDROGENASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0319409\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.135713\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23535623\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RDH8\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1780\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADENINE PHOSPHORIBOSYLTRANSFERASE (EC 2.4.2.7) (APRT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.273997\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.16418\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.235356216\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1781\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ESTRADIOL 17 BETA-DEHYDROGENASE 1 (EC 1.1.1.62) (17-BETA-HSD 1) (PLACENTAL 17-BETA-HYDROXYSTEROID DEHYDROGENASE) (20 ALPHA- HYDROXYSTEROID DEHYDROGENASE) (20-ALPHA-HSD) (E2DH). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0258082\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.109656\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.235356022\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HSD17B1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1782\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
17 BETA-HYDROXYSTEROID DEHYDROGENASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.024834\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.105517\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23535544\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1783\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PUTATIVE SIALOGLYCOPROTEASE TYPE 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.365106\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.55176\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.235285096\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
OSGEPL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1784\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"C-1-TETRAHYDROFOLATE SYNTHASE, CYTOPLASMIC (C1-THF SYNTHASE) [INCLUDES: METHYLENETETRAHYDROFOLATE DEHYDROGENASE (EC 1.5.1.5); METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE (EC 3.5.4.9); FORMYLTETRAHYDROFOLATE SYNTHETASE (EC 6.3.4.3)]. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.156153\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.663781\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23524777\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MTHFD1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1785\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
S-ADENOSYLMETHIONINE SYNTHETASE GAMMA FORM (EC 2.5.1.6) (METHIONINE ADENOSYLTRANSFERASE) (ADOMET SYNTHETASE) (MAT-II). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.51691\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.19829\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23514186\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAT2A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1786\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ARGINASE II, MITOCHONDRIAL PRECURSOR (EC 3.5.3.1) (NON-HEPATIC ARGINASE) (KIDNEY-TYPE ARGINASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.18522\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.787708\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.235137894\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARG2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1787\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PREFOLDIN SUBUNIT 3 (VON HIPPEL-LINDAU BINDING PROTEIN 1) (VHL BINDING PROTEIN-1) (VBP-1) (HIBBJ46). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0305539\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.129981\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.235064356\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
VBP1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1788\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UXT PROTEIN (UBIQUITOUSLY EXPRESSED TRANSCRIPT PROTEIN) (HSPC024). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
UXT\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1789\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PREFOLDIN SUBUNIT 2 (HSPC231). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.15115\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.643016\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.235064135\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PFDN2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1790\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARGINASE 1 (EC 3.5.3.1) (LIVER-TYPE ARGINASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.222245\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.945747\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.234994137\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARG1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1791\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DNA-DIRECTED RNA POLYMERASES III 12.5 KDA POLYPEPTIDE (EC 2.7.7.6) (RNA POLYMERASE III C11 SUBUNIT) (HSC11P) (HRPC11) (MY010 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.163024\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.693873\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.234947894\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
POLR3K\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1792\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIMERIC DIHYDRODIOL DEHYDROGENASE; 3-DEOXYGLUCOSONE REDUCTASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0986496\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.419992\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.234884474\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DHDH\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1793\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"HEXAPRENYLDIHYDROXYBENZOATE METHYLTRANSFERASE, MITOCHONDRIAL PRECURSOR (EC 2.1.1.114) (DIHYDROXYHEXAPRENYLBENZOATE METHYLTRANSFERASE) (3,4- DIHYDROXY-5-HEXAPRENYLBENZOATE METHYLTRANSFERASE) (DHHB METHYLTRANSFERASE) (DHHB-MT) (DHHB-MTASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0303966\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.129436\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.234838839\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
COQ3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1794\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GUANINE DEAMINASE (EC 3.5.4.3) (GUANASE) (GUANINE AMINASE) (GUANINE AMINOHYDROLASE) (GAH) (P51-NEDASIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.234676\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.999309\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.234838273\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GDA\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1795\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ATP SYNTHASE COUPLING FACTOR B, MITOCHONDRIAL PRECURSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0303657\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.129305\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.234837787\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP5S\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1796\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROGRAMMED CELL DEATH PROTEIN 5 (TFAR19 PROTEIN) (TF-1 CELL APOPTOSIS RELATED GENE-19 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.218499\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.930463\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.234828252\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PDCD5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1797\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DNA TOPOISOMERASE III ALPHA (EC 5.99.1.2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.09162\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.390211\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.234796046\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TOP3A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1798\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"FOLYLPOLYGLUTAMATE SYNTHASE, MITOCHONDRIAL PRECURSOR (EC 6.3.2.17) (FOLYLPOLY-GAMMA-GLUTAMATE SYNTHETASE) (FPGS). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.107427\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.457652\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.234735126\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FPGS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1799\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0461397\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.196587\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.234703719\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FAM57B\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1800\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.0580492\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.247338\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.234695841\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/